Lyell Immunopharma

Lyell Immunopharma

Biotechnology, 201 Haskins Way, South San Francisco, California, 94080, United States, 201-500 Employees

lyell.com

  • facebook
  • LinkedIn

phone no Phone Number: 65********

Who is LYELL IMMUNOPHARMA

Using living cells to treat and sometimes even cure cancer is one of the most dramatic advances in modern medicine. Patients with hematologic malignancies have been successfully treated w...

Read More

map
  • 201 Haskins Way, South San Francisco, California, 94080, United States Headquarters: 201 Haskins Way, South San Francisco, California, 94080, United States
  • 2018 Date Founded: 2018
  • 201-500 Employees: 201-500
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from LYELL IMMUNOPHARMA

Lyell Immunopharma Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Lyell Immunopharma

Answer: Lyell Immunopharma's headquarters are located at 201 Haskins Way, South San Francisco, California, 94080, United States

Answer: Lyell Immunopharma's phone number is 65********

Answer: Lyell Immunopharma's official website is https://lyell.com

Answer: Lyell Immunopharma's revenue is $1 Million to $5 Million

Answer: Lyell Immunopharma's SIC: 2836

Answer: Lyell Immunopharma's NAICS: 541714

Answer: Lyell Immunopharma has 201-500 employees

Answer: Lyell Immunopharma is in Biotechnology

Answer: Lyell Immunopharma contact info: Phone number: 65******** Website: https://lyell.com

Answer: Using living cells to treat and sometimes even cure cancer is one of the most dramatic advances in modern medicine. Patients with hematologic malignancies have been successfully treated with cell therapies. However, these profound results have not yet been achieved in patients with solid tumors, representing approximately 90% of all cancers. At Lyell, our goal is to change that. We are a clinical-stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for solid tumors based on our innovative technologies. We were founded by cell therapy pioneers whose decades of research elevated the broader understanding of T-cell biology and its interaction with cancer. In our quest to defeat solid tumors, we have built a fully integrated company capable of discovering new technologies, translating science into therapies, manufacturing cell therapy products, and clinically evaluating them in patients. Our culture is based on Science, Respect, Collaboration, and Courage and reflects who we are, the environment we create, and our mission's urgency.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access